Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0059 | 0.3119 | 0.9706 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0134 | 1 | 0.5 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0063 | 0.3404 | 1 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0038 | 0.1149 | 0.1149 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0071 | 0.4172 | 0.4172 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0134 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0059 | 0.3119 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0059 | 0.3119 | 0.9706 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0071 | 0.4172 | 0.3415 |
Schistosoma mansoni | 6-phosphofructokinase | 0.006 | 0.3213 | 0.2332 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.006 | 0.3213 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0071 | 0.4172 | 0.3584 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.3119 | 0.8896 |
Echinococcus granulosus | 6 phosphofructo 2 kinase:fructose 2 | 0.006 | 0.3213 | 0.2332 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0134 | 1 | 1 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0038 | 0.1149 | 0.3576 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0038 | 0.1149 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1149 | 0.1268 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.006 | 0.3213 | 0.2332 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0134 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0038 | 0.1149 | 0.5 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0038 | 0.1149 | 0.3576 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0071 | 0.4172 | 0.3415 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0038 | 0.1149 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0071 | 0.4172 | 0.3584 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0134 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0059 | 0.3119 | 0.3119 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0134 | 1 | 1 |
Onchocerca volvulus | 0.006 | 0.3213 | 0.5 | |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0038 | 0.1149 | 0.3576 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0134 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0134 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.006 | 0.3213 | 0.3213 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0071 | 0.4172 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0134 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0038 | 0.1149 | 0.5 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0071 | 0.4172 | 0.3415 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.006 | 0.3213 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3213 | 0.9262 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.006 | 0.3213 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0038 | 0.1149 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.